TheraRadar
← Back
Data updated: Jun 28, 2026

ZHEJIANG XIANJU

Generics
Pharmaceuticals

ZHEJIANG XIANJU is a generic drug manufacturer with 1 FDA-approved products.

2024
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

ZHEJIANG XIANJU's Key Drugs

ZHEJIANG XIANJU's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

ZHEJIANG XIANJU's Recent FDA Approvals

New NDA/BLA approvals for ZHEJIANG XIANJU over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

ZHEJIANG XIANJU's Therapeutic Areas

Disease areas where ZHEJIANG XIANJU has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

ZHEJIANG XIANJU Pipeline Snapshot

Active clinical trials for ZHEJIANG XIANJU across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling